Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
Laura W. Dillon, Gege Gui, Niveditha Ravindra, et al.
JAMA Oncology (2024) Vol. 10, Iss. 8, pp. 1104-1104
Open Access | Times Cited: 16

Showing 16 citing articles:

Clinico‐Genomic Interrogation of Secondary‐Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies
Jayastu Senapati, Sanam Loghavi, Jennifer Marvin‐Peek, et al.
American Journal of Hematology (2025)
Closed Access | Times Cited: 1
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management
Shai Shimony, Maximilian Stahl, Richard M. Stone
American Journal of Hematology (2025)
Open Access | Times Cited: 1
Biology and Management of Acute Myeloid Leukemia With Mutated NPM1
Evan C. Chen, Shai Shimony, Marlise R. Luskin, et al.
American Journal of Hematology (2025)
Closed Access
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies
Scott D. Rowley, Maher Albitar, Melissa Baker, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 625-625
Open Access
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
Jayastu Senapati, Tapan M. Kadia, Naval Daver, et al.
Cancer (2025) Vol. 131, Iss. 7
Closed Access
Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)
Carlos Jiménez‐Vicente, Jordi Esteve, Mónica Baile-González, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Endoplasmic Reticulum Stress in Acute Myeloid Leukemia: Pathogenesis, Prognostic Implications, and Therapeutic Strategies
Wojciech Wiese, Grzegorz Galita, Natalia Siwecka, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3092-3092
Open Access
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Gege Gui, Niveditha Ravindra, Pranay S. Hegde, et al.
Bone Marrow Transplantation (2024)
Open Access | Times Cited: 3
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia
Pranay S. Hegde, Georgia Andrew, Gege Gui, et al.
Bone Marrow Transplantation (2024)
Open Access | Times Cited: 2
Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?
Firas El Chaer, Anthony J. Perissinotti, Sanam Loghavi, et al.
Leukemia (2024)
Closed Access | Times Cited: 2
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Gege Gui, Niveditha Ravindra, Pranay S. Hegde, et al.
Bone Marrow Transplantation (2024)
Open Access | Times Cited: 2
Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice
Brian C. Shaffer, Partow Kebriaei, Marcos de Lima, et al.
Bone Marrow Transplantation (2024)
Open Access
Early drivers of clonal hematopoiesis shape the evolutionary trajectories of de novo acute myeloid leukemia
Ryan D. Chow, Priya Velu, Safoora Deihimi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Precision medicine results from equitable representation
Alexandra Gomez-Arteaga, Nora Chokr, Jeffery J. Auletta
Bone Marrow Transplantation (2024)
Closed Access
Role of the CIBMTR biorepository and registry in precision transplantation research
Ryan Guerrettaz, Stephen R. Spellman, Kristin Page
Bone Marrow Transplantation (2024)
Open Access
Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient
Michael Heuser, Rabia Shahswar
Hematology (2024) Vol. 2024, Iss. 1, pp. 158-167
Closed Access
Mutations and MRD: clinical implications of clonal ontogeny
Jerald P. Radich
Hematology (2024) Vol. 2024, Iss. 1, pp. 150-157
Closed Access
Page 1

Scroll to top